IDH3A and glioblastoma: In this report, we prospectively enrolled a cohort of patients with isocitrate dehydrogenase (IDH) wildtype glioblastoma, as defined by the new World Health Organization classification, and performed untargeted metabolomics before and after surgery, as well as before and after concurrent chemoradiation.